The Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
BMJ Open. 2024 Jun 10;14(6):e076763. doi: 10.1136/bmjopen-2023-076763.
Transurethral resection of bladder tumour (TURBT) is one of the more common procedures performed by urologists. It is often described as an 'incision-free' and 'well-tolerated' operation. However, many patients experience distress and discomfort with the procedure. Substantial opportunity exists to improve the TURBT experience. An enhanced recovery after surgery (ERAS) protocol designed by patients with bladder cancer and their providers has been developed.
This is a single-centre, randomised controlled trial to investigate the effectiveness of an ERAS protocol compared with usual care in patients with bladder cancer undergoing ambulatory TURBT. The ERAS protocol is composed of preoperative, intraoperative and postoperative components designed to optimise each phase of perioperative care. 100 patients with suspected or known bladder cancer aged ≥18 years undergoing initial or repeat ambulatory TURBT will be enrolled. The change in Quality of Recovery 15 score, a measure of the quality of recovery, between the day of surgery and postoperative day 1 will be compared between the ERAS and control groups.
The trial has been approved by the Johns Hopkins Institutional Review Board #00392063. Participants will provide informed consent to participate before taking part in the study. Results will be reported in a separate publication.
NCT05905276.
经尿道膀胱肿瘤切除术（TURBT）是泌尿科医生进行的较为常见的手术之一。它通常被描述为一种“无切口”和“耐受良好”的操作。然而，许多患者在手术过程中会感到痛苦和不适。有很大的机会可以改善 TURBT 的体验。已经为膀胱癌患者及其治疗师制定了一个增强术后恢复（ERAS）方案。
这是一项单中心、随机对照试验，旨在研究 ERAS 方案与膀胱癌患者行门诊 TURBT 时的常规护理相比的有效性。ERAS 方案由术前、术中、术后各阶段组成，旨在优化围手术期护理的各个阶段。将招募 100 名年龄≥18 岁、疑似或已知膀胱癌、行初次或重复门诊 TURBT 的患者。将比较 ERAS 组和对照组之间手术当天和术后第 1 天之间 15 分恢复质量评分（衡量恢复质量的指标）的变化。
该试验已获得约翰霍普金斯机构审查委员会 #00392063 的批准。参与者将在参与研究之前提供知情同意书。结果将在另一个出版物中报告。
NCT05905276。
Zotero 插件